Metallobodies: Hybrid Technology for Biomolecular Recognition

Tailored detection projects designed for our customers

Our technology

Melisa Platform

Our metallobodies are based on Hybrid Mimetic Antigens allows rapid and specific detection of multiple targets

MEtaLlic Immuno-Scaffold Assay is a versatile platform for biomolecular recognition…

MELISA offers endless possibilities in biomolecular recognition

1

Batch-to-Batch Reproducibility

2

Robustness and Stability

3

Versatility

4

Tailored for each need

5

Fast and Cost-effective manufacturability

6

Ethical and sustainable

Binder and reporter in the same molecule

Binding protein sequence is engineered specifically for each target

The metal cluster is used as reporter: photoluminescent, catalytic, electroactive, magnetic

Detection aplications and use cases

Antibody

Antigens

Proteins

Cancer cells

Nanobodies

More coming

Solutions

Antibody Detection

The platform based on our metallobodies allows rapid and specific detection of multiple antibodies.

Tailored Detectors for Diverse specific Targets

Solutions

Targeted MRI Contrast Agents

The technology platform enables the detection of diverse biomolecules by MRI through specific, targeted contrast agents.

Custom-designed protein recognition domains are  developed for each case in a tailored project.

Intellectual property

Solid Intellectual Property Position

The patent, property of CIC biomaGUNE, has been exclusively licensed to TALDEKI Biosolutions, indefinitely and across all covered territories.

Protects reagents, production process, and uses therof.

Team

Meet us

We Are a Multidisciplinary Team Turning Science into Impact

CEO

Pablo Ferrón Celma

Entrepreneur with 14 years of experience building companies.

MSc in Chemistry, author of 5 scientific publications, and holder of 7 patents.

Expert in team leadership, innovation management, and intellectual property.

CSO

Aitziber López Cortajarena

PhD in Biochemistry, Ikerbasque Research Professor at CIC biomaGUNE.

Over 120 peer-reviewed publications and 8 patents.

Expert in protein engineering dedicated to develop protein-based solutions for biomedical applications.

Strategic Advisor

Marcos Simón

Experienced entrepreneur with a strong background in company creation.

Technology Transfer Officer at CIC biomaGUNE and scientist with multiple publications and patents.

Skilled in advising and leading technology transfer processes.

Business Dev. Advisor

Fernando Agirre

Expert in business development, M&A, and securing funding, focusing on Deeptech companies and spin-offs from research-intensive organizations and academia.

Ability to scale innovative businesses within market positioning.

Mission

To replace traditional antibodies in biomolecular detection with metal-protein hybrid sensors, providing a more stable, reproducible, and faster-to-produce solution. We focus on delivering speed in design, cost-effective products, and customized solutions tailored to each client’s specific needs.

Our goal is to drive a paradigm shift in antibody detection, transforming diagnostics with long-term innovation and reliability.

Vision

To be globally recognized as leaders in detection solutions, revolutionizing diagnostics with metal-protein hybrid molecules that replace traditional technologies. We aspire to transform the industry toward faster, more robust, and accessible methods, setting a new standard of reliability and efficiency in antibody detection.

Supported by

Contact

Let's talk

If you would like more information, please contact us. We would be happy to arrange a meeting to discuss further.

    Full name


    Email


    Company


    Country


    Sector


    Message